| Market revenue in 2025 | USD 10.3 million |
| Market revenue in 2033 | USD 20.2 million |
| Growth rate | 9% (CAGR from 2026 to 2033) |
| Largest segment | Synthetic |
| Fastest growing segment | Natural |
| Historical data | 2021 - 2024 |
| Base year | 2025 |
| Forecast period | 2026 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Natural, Synthetic |
| Key market players worldwide | Ceapro, Cosciens, Symrise AG, Henan Steeda Industrial Co. |
Publish Date: Oct 13, 2025
Last Updated: Aug 26, 2026
No credit card required*
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Symrise AG | View profile | 12,435 | Muhlenfeldstrasse 1, Holzminden, ST, Germany, 37603 | www.symrise.com |
| Cosciens | View profile | 11-50 | Summerville, South Carolina, United States, North America | www.cosciensbio.com |
| Ceapro | View profile | 11-50 | Edmonton, Alberta, Canada, North America | ceapro.com |
| Henan Steeda Industrial Co. | View profile | 11-50 | Zhengzhou, Henan, China, Asia | www.tgbotanicals.com |
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Avenanthramides Market Outlook will help companies and investors design strategic landscapes.
Synthetic was the largest segment with a revenue share of 97.09% in 2025.
Horizon Databook has segmented the Germany avenanthramides market based on natural, synthetic covering the revenue growth of each sub-segment from 2021 to 2033.
Horizon Databook provides a detailed overview of country-level data and insights on the Germany Avenanthramides Market Outlook, including forecasts for subscribers. This country databook contains high-level insights into Germany Avenanthramides Market Outlook from 2021 to 2033, including revenue numbers, major trends, and company profiles.